Methylated circulating tumor DNA (Met-DNA) is an independent prognostic factor in metastatic pancreatic adenocarcinoma (mPAC) patients.

D. Pietrasz, S. Wang-Renault, L. Dahan, J. Taieb, K. Le Malicot, Y. Renaldi, S. Doat, J. M. Phelip, V. Taly, J. B. Bachet, P. Laurent-Puig